Complicated Intra-Abdominal Infections (cIAIs) Completed Phase 2 Trials for Tazobactam (DB01606)

Also known as: Complicated Intra-abdominal Infection (cIAI) / Complicated Intra-Abdominal Infections, cIAIs / Complicated Intraabdominal Infections / Intra Abdominal Infections Complicated / Complicated Intra Abdominal Infections / Complicated Intra-Abdominal Infection / Complicated Intra-Abdominal Infections / Abdominal infection / Infectious disease of abdomen (disorder) / Intra-abdominal infection / Intraabdominal Infections

IndicationStatusPhase
DBCOND0079243 (Complicated Intra-Abdominal Infections (cIAIs))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03217136MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)Treatment
NCT01147640Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal InfectionsTreatment